4.6 Article

Staging of α-Synuclein in the Olfactory Bulb in a Model of Parkinson's Disease: Cell Types Involved

Journal

MOVEMENT DISORDERS
Volume 25, Issue 11, Pages 1701-1707

Publisher

WILEY
DOI: 10.1002/mds.23197

Keywords

alpha-Synuclein; calcium binding protein; olfactory bulb; olfactory deficit; Parkinson's disease; transgenic mice; tyrosine hydroxylase

Funding

  1. Autonomous Government of Castilla-La Mancha-FEDER [PI-2006/15, GCS-2006 E/03, PCC08-0064]

Ask authors/readers for more resources

Impaired olfaction is an early symptom of Parkinson's disease. The underlying neuropathology likely includes alpha-synucleinopathy in the olfactory bulb at an earlier stage (Braak's stagel) than pathology in the substantia nigra, which is not observed until stage 3. In this report, we investigated the distribution and cell types affected by alpha-synuclein in the olfactory bulb of transgenic mice (2-8 months of age) expressing the human A53T variant of alpha-synuclein. alpha-Synuclein immunostaining progressively affects interneurons and mitral cells. Double labeling studies demonstrate that dopaminergic cells are hardly involved, whereas glutamatergic- and calcium binding protein-positive cells are severely affected. This temporal evolution and the cell types expressing a-synuclein are reminiscent of idiopathic Parkinson's disease and support the usefulness of this model to address specific topics in the premotor phase of the disease. (C) 2010 Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available